UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 40,868 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 3.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,158,390 shares of the company’s stock after acquiring an additional 40,868 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Bath & Body Works were worth $36,976,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Lone Pine Capital LLC raised its stake in Bath & Body Works by 15.8% during the 2nd quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after purchasing an additional 1,547,399 shares during the last quarter. Anomaly Capital Management LP acquired a new position in shares of Bath & Body Works during the second quarter valued at about $113,995,000. FMR LLC lifted its stake in shares of Bath & Body Works by 17,496.5% in the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock valued at $80,315,000 after buying an additional 2,501,828 shares during the period. Sound Shore Management Inc. CT grew its position in Bath & Body Works by 10.0% during the second quarter. Sound Shore Management Inc. CT now owns 2,088,703 shares of the company’s stock worth $81,564,000 after buying an additional 189,889 shares in the last quarter. Finally, KBC Group NV grew its position in Bath & Body Works by 9,023.5% during the third quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after buying an additional 1,683,160 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Down 1.6 %

Shares of NYSE BBWI opened at $36.90 on Wednesday. The company has a market cap of $7.99 billion, a price-to-earnings ratio of 9.00, a price-to-earnings-growth ratio of 1.40 and a beta of 1.83. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99. The firm’s 50-day simple moving average is $31.33 and its 200 day simple moving average is $35.30.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter last year, the business posted $0.48 earnings per share. Bath & Body Works’s revenue for the quarter was up 3.1% compared to the same quarter last year. On average, equities analysts expect that Bath & Body Works, Inc. will post 3.26 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.17%. The ex-dividend date of this dividend is Friday, November 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Insider Activity at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell bought 6,000 shares of the company’s stock in a transaction on Wednesday, October 9th. The stock was bought at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. The trade was a 2.53 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts have commented on BBWI shares. Morgan Stanley reduced their price objective on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Evercore ISI reduced their target price on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a research report on Wednesday, August 28th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. BMO Capital Markets reaffirmed an “outperform” rating and set a $50.00 price objective (down from $52.00) on shares of Bath & Body Works in a report on Thursday, August 29th. Finally, JPMorgan Chase & Co. upped their target price on shares of Bath & Body Works from $35.00 to $39.00 and gave the company a “neutral” rating in a research note on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, Bath & Body Works has a consensus rating of “Moderate Buy” and a consensus price target of $41.88.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.